Effect of bisphosphonate (Incadronate) on fracture healing of long bones in rats.
Abstract
This study was designed to test whether bisphosphonates disturb the process of fracture healing. Female Sprague-Dawley rats were injected with either two doses of bisphosphonate (incadronate) (10 μg/kg and 100 μg/kg) or vehicle three times a week for 2 weeks. Right femora were then fractured and fixed with intramedullary wires. Incadronate treatment was stopped in pretreatment groups (P-10 and P-100 groups), while the treatment was continued in continuous treatment groups (C-10 and C-100 groups). Animals were sacrificed at 6 and 16 weeks after surgery. Soft X-ray of all fractured femora was taken. After mechanical testing, fractured femora were stained in Villanueva bone stain and embedded in methyl methacrylate. Cross-sections near fracture line were analyzed by microradiography and histomorphometry. Radiographic study showed that bony callus was present in all the fractures and incadronate treatment led to a larger callus, especially in C-100 group at both 6 and 16 weeks. Histologic study showed that the process of fracture healing in pretreatment groups was delayed at 6 weeks, but reached control level thereafter and showed same characteristics as in control at 16 weeks. Woven bony callus could still be seen in continuous treatment groups at 16 weeks. Mechanical study indicated that the ultimate load of C-100 group was slightly higher than the other treatment groups and control. The results suggest that pretreatment with incadronate did not affect fracture healing at 16 weeks after fracture. However, continuous incadronate treatment could lead to larger callus, but it delayed remodeling process during fracture healing, especially with high-dose treatment.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The larger calluses at week 8 are consistent with delayed callus remodeling, a phenomenon typically associated with bisphosphonates and other antiresorptive therapies.
“These findings are consistent with a delay in callus remodeling, a phenomenon that is typically associated with bisphosphonates and other antiresorptive therapies in similar models (364 -366).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [365]
Cites
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846 · see citing works
The Cell and Molecular Biology of Fracture Healing
Einhorn, T. A. (1998) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199810001-00003 · Cited by 1,280 · see citing works
The biology of fracture healing in long bones
McKibbin, B. (1978) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.60b2.350882 · Cited by 1,183 · see citing works
Bisphosphonates: Mechanisms of Action
Fleisch, H. A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.1.0325 · Cited by 1,015 · see citing works
Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis
Watts, N. B., Harris, S. T., Genant, H. K., Wasnich, R. D., Miller, P. D., Jackson, R. D., Licata, A. A., Ross, P. D., Woodson, G. C., Yanover, M., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007123230201 · Cited by 947 · see citing works
Storm, T., Thamsborg, G., Steiniche, T., Genant, H. K., & Sørensen, O. H. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221803 · Cited by 932 · see citing works
The biology of fracture healing. An overview for clinicians. Part I.
Frost, H. M. (1989) · PubMed · Cited by 600 · see citing works
Fleisch, H. A. (1991) · Drugs · doi:10.2165/00003495-199142060-00003 · Cited by 584 · see citing works
Schenk, R., Merz, W. A., Mühlbauer, R. C., Russell, R. G. G., & Fleisch, H. A. (1973) · Calcified Tissue International · doi:10.1007/bf02547219 · Cited by 482 · see citing works
Growth factors for bone growth and repair: IGF, TGFβ and BMP
Linkhart, T. A., Mohan, S., & Baylink, D. J. (1996) · Bone · doi:10.1016/s8756-3282(96)00138-x · Cited by 440 · see citing works
Parfitt, A. M. (1984) · Calcified Tissue International · doi:10.1007/bf02406132 · Cited by 406 · see citing works
Hughes, D. E., MacDonald, B. R., Russell, R. G. G., & Gowen, M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114100 · Cited by 357 · see citing works
Deregulated c-fos expression interferes with normal bone development in transgenic mice
Rüther, U., Garber, C., Komitowski, D. D., Müller, R., & Wagner, E. F. (1987) · Nature · doi:10.1038/325412a0 · Cited by 332 · see citing works
Giuliani, N., Pedrazzoni, M., Negri, G., Passeri, G., Impicciatore, M., & Girasole, G. (1998) · Bone · doi:10.1016/s8756-3282(98)00033-7 · Cited by 269 · see citing works
Effects of bisphosphonates on isolated Rat osteoclasts as examined by reflected light microscopy
Sato, M., & Grasser, W. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650050107 · Cited by 264 · see citing works
Current Concepts of Fracture Healing
Hulth, A. G. (1989) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198912000-00028 · Cited by 227 · see citing works
Murakami, H., Takahashi, N., Sasaki, T., Udagawa, N., Tanaka, S., Nakamura, I., Zhang, D., Barbier, A., & Suda, T. (1995) · Bone · doi:10.1016/s8756-3282(95)00150-6 · Cited by 218 · see citing works
Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis
Watts, N. B., Harris, S. T., Genant, H. K., WASNICH, E. D., Miller, P. D., Jackson, R. D., Licata, A. A., Ross, P. D., Woodson, G. C., Yanover, M., et al. (1991) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199101000-00023 · Cited by 190 · see citing works
Fitton, A., & McTavish, D. (1991) · Drugs · doi:10.2165/00003495-199141020-00009 · Cited by 189 · see citing works
Effect of alendronate on fracture healing and bone remodeling in dogs
Peter, C. P., Cook, W. O., Nunamaker, D. M., Provost, M. T., Seedor, J. G., & Rodan, G. A. (1996) · Journal of Orthopaedic Research® · doi:10.1002/jor.1100140113 · Cited by 185 · see citing works
Enhanced expression of TGF-β and c-fos mRNAs in the growth plates of developing human long bones
Sandberg, M., Vuorio, T. K., Hirvonen, H., Alitalo, K. K., & Vuorio, E. (1988) · Development · doi:10.1242/dev.102.3.461 · Cited by 170 · see citing works
Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures
Nishikawa, M., Akatsu, T., Katayama, Y., Yasutomo, Y., Kado, S., Kugai, N., Yamamoto, M., & Nagata, N. (1996) · Bone · doi:10.1016/8756-3282(95)00426-2 · Cited by 161 · see citing works
Plosker, G. L., & Goa, K. L. (1994) · Drugs · doi:10.2165/00003495-199447060-00007 · Cited by 111 · see citing works
The long-term skeletal effects of EHDP in dogs
Flora, L., Hassing, G. S., Cloyd, G. G., et al. (1981) · Metabolic Bone Disease and Related Research · doi:10.1016/0221-8747(81)90045-x · Cited by 100 · see citing works
Influence of Age on Mechanical Properties of Healing Fractures and Intact Bones in Rats
Ekeland, A., Lb, E., & Langeland, N. (1982) · Acta Orthopaedica Scandinavica · doi:10.3109/17453678208992252 · Cited by 100 · see citing works
Lin, J. H., Chen, I. W., & Duggan, D. E. (1992) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08706-9 · Cited by 99 · see citing works
In situ localization of collagen production by chondrocytes and osteoblasts in fracture callus.
Sandberg, M., Aro, H. T., Multimäki, P., et al. (1989) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-198971010-00012 · Cited by 94 · see citing works
New bisphosphonates in osteoporosis
Fleisch, H. A. (1993) · Osteoporosis International · doi:10.1007/bf01623222 · Cited by 86 · see citing works
Effect of EHDP on fracture healing in dogs
Lenehan, T. M., Balligand, M. H., Nunamaker, D. M., & Wood, F. E. (1985) · Journal of Orthopaedic Research® · doi:10.1002/jor.1100030413 · Cited by 85 · see citing works
The Biology of Fracture Healing
Frost, H. M. (1989) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198911000-00045 · Cited by 85 · see citing works
Panetta, N. J., Gupta, D. M., & Longaker, M. T. (2010) · Current Stem Cell Research & Therapy · doi:10.2174/157488810791268618 · Cited by 83 · see citing works
Facilitation and suppression of bone metastasis.
Mundy, G. R., & Yoneda, T. (1995) · PubMed · Cited by 81 · see citing works
Use of a bisphosphonate (pamidronate) to modulate fracture repair in ovine bone.
Goodship, A. E., Walker, P., McNally, D. S., et al. (1994) · PubMed · Cited by 79 · see citing works
Retention of etidronate in human, dog, and rat
Kasting, G. B., & Francis, M. D. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070507 · Cited by 76 · see citing works
Histomorphometry of Distraction Osteogenesis in a Caprine Tibial Lengthening Model
Welch, R. D., Birch, J. G., Makarov, M. R., et al. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.1.1 · Cited by 73 · see citing works
Inhibitory effects of bisphosphonate (YM175) on bone resorption induced by a metastatic bone tumor
Hiraga, T., Tanaka, S., Yamamoto, M., Nakajima, T., & Ozawa, H. (1996) · Bone · doi:10.1016/8756-3282(95)00428-9 · Cited by 66 · see citing works
Motoie, H., Nakamura, T., O'uchi, N., Nishikawa, H., Kanoh, H., Abe, T., & Kawashima, H. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100612 · Cited by 54 · see citing works
A biomechanical study of the effects of growth hormone in experimental fracture healing
Northmore-Ball, M., Wood, M. B., & Meggitt, B. (1980) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.62b3.7410474 · Cited by 52 · see citing works
The effect of growth hormone on fracture healing in old rats
Bak, B., & Andreassen, T. T. (1991) · Bone · doi:10.1016/8756-3282(91)90037-j · Cited by 47 · see citing works
Clodronate increases the calcium content in fracture callus
Nyman, M. T., Paavolainen, P., & Lindholm, T. S. (1993) · Archives of Orthopaedic and Trauma Surgery · doi:10.1007/bf00451880 · Cited by 43 · see citing works
Effect of clodronate on fracture healing in denervated rats
Tarvainen, R., Olkkonen, H., Nevalainen, T., Hyvönen, P. M., Arnala, I., & Alhava, E. M. (1994) · Bone · doi:10.1016/8756-3282(94)90320-4 · Cited by 40 · see citing works
Black, J. T., Perdigon, P., Brown, N., et al. (1984) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198401000-00037 · Cited by 40 · see citing works
Internal remodeling of periosteal new bone during fracture healing
Aro, H. T., Wippermann, B. W., Hodgson, S. F., et al. (1990) · Journal of Orthopaedic Research® · doi:10.1002/jor.1100080213 · Cited by 39 · see citing works
Neutral protein‐degrading enzymes in experimental fracture callus: A preliminary report
Einhorn, T. A., Hirschman, A. O. H., Kaplan, C., Nashed, R., Devlin, V. J., & Warman, J. (1989) · Journal of Orthopaedic Research® · doi:10.1002/jor.1100070604 · Cited by 36 · see citing works
Standardization of tibial fractures in the rat
Bak, B., & Jensen, K. S. (1992) · Bone · doi:10.1016/8756-3282(92)90073-6 · Cited by 33 · see citing works
Healing of a tibial double osteotomy is modified by clodronate administration
Nyman, M. T., Gao, T., Lindholm, T. C., & Lindholm, T. S. (1996) · Archives of Orthopaedic and Trauma Surgery · doi:10.1007/bf00573453 · Cited by 30 · see citing works
Comparison of three intravenous regimens of clodronate in paget disease of bone
Khan, S. A., McCloskey, E. V., Eyres, K. S., Nakatsuka, K., Sirtori, P. L., Orgee, J., Coombes, G., & Kanis, J. А. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110206 · Cited by 28 · see citing works
Pharmacokinetics of YM175, a new bisphosphonate, in rats and dogs.
Usui, T., Watanabe, T., & Higuchi, S. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06818-7 · Cited by 20 · see citing works
Li, J., Mori, S., Mashiba, T., et al. (1998) · Bone · doi:10.1016/s8756-3282(98)00123-9 · Cited by 19 · see citing works
Self-citationNii, A., Fujimoto, R., Okazaki, A., et al. (1994) · Toxicologic Pathology · doi:10.1177/019262339402200509 · Cited by 18 · see citing works
ETIDRONATE AND RISK OF FRACTURES
Mugglestone, C. J. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91820-3 · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824 · see citing works
Cao, Y., Mori, S., Mashiba, T., Westmore, M. S., Ma, L., Sato, M., Akiyama, T., Shi, L., Komatsubara, S., Miyamoto, K., et al. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.12.2237 · Cited by 248 · see citing works
Self-citationEffects of receptor activator of NFκB (RANK) signaling blockade on fracture healing.
Flick, L. M., Weaver, J. M., Ulrich‐Vinther, M., Abuzzahab, F., Zhang, X., Dougall, W. C., Anderson, D., O'Keefe, R. J., & Schwarz, E. M. (2003) · Journal of Orthopaedic Research · doi:10.1016/s0736-0266(03)00011-1 · Cited by 82 · see citing works
Ulrich-Vinther, M., & Andreassen, T. T. (2005) · Calcified Tissue International · doi:10.1007/s00223-004-0126-9 · Cited by 46 · see citing works
- Authors
- Li, J., Mori, S., Kaji, Y., Mashiba, T., Kawanishi, J., & Norimatsu, H.
- Affiliations
- Kagawa University (JP)
- Corresponding author
- Mori, Satoshi
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-06-01
- Volume
- 14
- Issue
- 6
- Pages
- 969-979
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W1973514169
- Cited by
- 178
- References
- 51
- Citations by year
- 2026: 4 · 2024: 5 · 2023: 2 · 2022: 4 · 2021: 8 · 2020: 6 · 2019: 6 · 2018: 3 · 2017: 7 · 2016: 7 · 2015: 8 · 2014: 9 · 2013: 6 · 2012: 7
- FWCI
- 1.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Bone and Mineral Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Epidemiology › Bone fractures and treatments
- Keywords
- bisphosphonates, incadronate, fracture healing, long bones, femoral fracture, bone callus, bone remodeling, intramedullary fixation, histomorphometry, ultimate load, dose-dependent effects
- MeSH terms
- Animals, Bone and Bones, Bony Callus, Diphosphonates, Drug Administration Schedule, Drug Evaluation, Preclinical, Female, Radiography, Stress, Mechanical, Fracture Healing, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review